Kura Oncology, Inc. (KURA) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
KURA currently has 87.6M outstanding shares. with minimal authorized share overhang for future dilution. The company has diluted shareholders by 13.99% over the past 2 years through share issuances.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| Nov 04, 2025 |
10-Q filing | 87.6M shares outstanding |
88M | 0 |
| Aug 07, 2025 |
10-Q filing | 87.6M shares outstanding |
88M | 0 |
| May 01, 2025 |
10-Q filing | 87.4M shares outstanding |
87M | 0 |
| Feb 28, 2025 |
10-K filing | 86.2M shares outstanding |
86M | 0 |
| Nov 07, 2024 |
10-Q filing | 77.8M shares outstanding |
78M | 0 |
| Aug 08, 2024 |
10-Q filing | 76.6M shares outstanding |
77M | 0 |
| May 02, 2024 |
10-Q filing | 76.2M shares outstanding |
76M | 0 |
| Feb 27, 2024 |
10-K filing | 73.2M shares outstanding |
73M | 0 |
| Feb 09, 2024 |
S-3 filing: This S-3 filing relates to the offer and resale of up to 8,695,699 shares of common stock by selling stockholders, including shares issuable upon exercise of pre-funded warrants. |
1.4M | 70M |
| Nov 02, 2023 |
10-Q filing | 77.2M shares outstanding |
77M | 0 |
| Aug 09, 2023 |
10-Q filing | 69.8M shares outstanding |
70M | 0 |
| May 10, 2023 |
10-Q filing | 68.4M shares outstanding |
68M | 0 |
| Feb 23, 2023 |
10-K filing | 67.0M shares outstanding |
67M | 0 |
| Nov 03, 2022 |
10-Q filing | 66.9M shares outstanding |
67M | 0 |
| Aug 03, 2022 |
10-Q filing | 66.7M shares outstanding |
67M | 0 |
| May 04, 2022 |
10-Q filing | 66.6M shares outstanding |
67M | 0 |
| Feb 24, 2022 |
10-K filing | 66.6M shares outstanding |
67M | 0 |
| Nov 04, 2021 |
10-Q filing | 66.6M shares outstanding |
67M | 0 |
| Aug 05, 2021 |
10-Q filing | 66.3M shares outstanding |
66M | 0 |
| May 06, 2021 |
10-Q filing | 66.3M shares outstanding |
66M | 0 |
| Feb 24, 2021 |
10-K filing | 66.2M shares outstanding |
66M | 0 |
| Nov 05, 2020 |
10-Q filing | 56.7M shares outstanding |
57M | 5.7M |
| Aug 06, 2020 |
10-Q filing | 56.3M shares outstanding |
56M | 6.2M |
| Aug 06, 2020 |
S-3 filing: The filing is an S-3 form for a shelf offering of common stock, preferred stock, debt securities, and warrants, with a total proposed amount of $300,000,000. The last reported sales price of the common stock was $17.64 on August 5, 2020. |
45M | 17M |
| May 04, 2020 |
10-Q filing | 45.4M shares outstanding |
45M | 0 |
| Feb 25, 2020 |
10-K filing | 45.4M shares outstanding |
45M | 0 |